{"id":1906,"date":"2019-09-26T18:29:17","date_gmt":"2019-09-26T16:29:17","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=1906"},"modified":"2024-06-19T14:22:38","modified_gmt":"2024-06-19T12:22:38","slug":"head-and-neck-diseases","status":"publish","type":"page","link":"https:\/\/idibell.cat\/en\/research\/cancer-area\/molecular-mechanisms-and-experimental-therapy-in-oncology-program-oncobell\/head-and-neck-diseases\/","title":{"rendered":"Head and neck diseases"},"content":{"rendered":"\n

\n\t\tHead and neck diseases\n\t<\/h1>\n

\n\t\tSummary\n\t<\/h3>\n\t

The Head and neck research group, as part of its line of cancer research, studies new therapeutic targets and predictive biomarkers of response to chemotherapy, radiotherapy and immunotherapy, the role of the human papilloma virus (HPV) and the differential management of HPV+ tumours, transoral treatment of laryngeal cancer with CO2 laser and robotic surgery, reconstructive surgery and pharyngeal rehabilitation of laryngectomised patients<\/p>\n

406<\/h2>\n

Publications<\/h2>\n\t\t\t\t\"511-malaltiescapcoll-mmanos-def\"\n\t\t\t\t\tStrategic lines<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t